Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Takeda CEO admits to Blopress mis-marketing

Takeda CEO admits to Blopress mis-marketing its blood pressure medicine Diovan (valsartan). ... That investigation centres on suggestions that data from trials was falsified to inflate the clinical benefits of Diovan.

Novartis under fire in Japan over Diovan promotion

Novartis under fire in Japan over Diovan promotion Offices raided amid investigation into falsified data. Novartis' Japanese subsidiary was raided yesterday as part of an investigation into allegations of mis-promotion of its hypertension drug Diovan. ... Diovan was the driver for Novartis' top-line

Novartis planning thousands more job cuts, says paper

Novartis planning thousands more job cuts, says paper The latest news comes after Novartis reported fourth-quarter earnings under pressure as a result of the loss of patent protection for Diovan (valsartan), its big-selling blood pressure drug, with

New York plant set to close as Novartis continues cutbacks

New York plant set to close as Novartis continues cutbacks The decision to close Suffern comes as Novartis is finally facing the start of generic competition to blood pressure blockbuster Diovan (valsartan) in the US, despite a delay caused by manufacturing ... Diovan is one of the main products made at the New

Who tops the pharma list?

Who tops the pharma list? By the end of 2012, Advair (GSK - $8.2bn), Singulair (Merck - $5.5bn) and Diovan (Novartis - $5.7bn) would be among many billion-dollar brands to lose exclusivity during the calendar

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics